1993
DOI: 10.1095/biolreprod48.2.325
|View full text |Cite
|
Sign up to set email alerts
|

A Factor(s) from a Rat Trophoblast Cell Line Inhibits Prolactin Secretion in Vitro and in Vivo1

Abstract: The purpose of the present study was to measure the inhibitory action of secretions from trophoblast cells on prolactin (PRL) secretion in cycling and pregnant rats, and to determine whether factor(s) from trophoblast cells act directly on anterior pituitary cells. A rat choriocarcinoma cell line (Rcho)--a line consisting of trophoblast cells, including differentiated giant cells that secrete members of the placental PRL family--was used. When Rcho cells (1 x 10(6) cells) were transplanted under the kidney cap… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

1993
1993
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 37 publications
0
6
0
Order By: Relevance
“…DA is another neurotransmitter that may be produced by the placenta where it can induce direct effects through various DA receptors, including D1 and D2 receptors (Ben‐Jonathan & Munsick, 1980; Kim et al, 1997; Kim, Koh, Kang, Paik, & Choi, 2001; Mao et al, 2020; Tomogane, Arbogast, Soares, Robertson, & Voogt, 1993; Vaillancourt et al, 1994; Zhu, Zhang, Chen, Liu, & Guo, 2002). Several lines of evidence support the placenta as a dopaminergic/adrenergic organ.…”
Section: Introductionmentioning
confidence: 99%
“…DA is another neurotransmitter that may be produced by the placenta where it can induce direct effects through various DA receptors, including D1 and D2 receptors (Ben‐Jonathan & Munsick, 1980; Kim et al, 1997; Kim, Koh, Kang, Paik, & Choi, 2001; Mao et al, 2020; Tomogane, Arbogast, Soares, Robertson, & Voogt, 1993; Vaillancourt et al, 1994; Zhu, Zhang, Chen, Liu, & Guo, 2002). Several lines of evidence support the placenta as a dopaminergic/adrenergic organ.…”
Section: Introductionmentioning
confidence: 99%
“…A role for the PLs in the regulation of tuberoinfundibular function is suggested by three lines of evidence: first, the rise in maternal rPL-I concentrations at mid-gestation coincides with a sus¬ tained increase in tuberoinfundibular dopaminergic activity and a consequent fall in pituitary prolactin secretion (Voogt et al 1982;Tonkowicz & Voogt, 1983;Arbogast & Voogt, 1991); secondly, hysterec¬ tomy of pregnant rats on days 11 or 12 of gestation triggers the resumption of pituitary prolactin surges (Voogt, 1980); and thirdly, the intraventricular ad¬ ministration of hPL or of culture media containing rPL-I stimulates tyrosine hydroxylase activity in tu¬ beroinfundibular neurones and suppresses circulating prolactin levels (Voogt, 1980;Demarest et al 1983;Voogt & DeGreef, 1989). The effect of rPL-I on prolactin secretion in vivo may be exerted at the level of the hypothalamus because purified rPL-I has no effect on prolactin secretion in isolated rat pituitary cells (Tomogane et al 1993).…”
Section: Discussionmentioning
confidence: 99%
“…Twice-daily (diurnal and nocturnal) surges of pituitary PRL act as principal luteotropic signals to form and activate the corpus luteum during early pregnancy. After the implantation of embryos, twice-daily PRL surges are inhibited by PL-I produced by the trophoblast, and PRL secretion remains at a nadir until shortly before parturition 63 . Trophoblast-derived PL-I takes over from pituitary PRL in mid-pregnancy, while PL-II also takes over from PL-I in late pregnancy.…”
Section: Biological Rolesmentioning
confidence: 99%